{"filing":{"accession_number":"0001839341-26-000005","cik":"0001839341","ticker":"CORZZ","company_name":"Core Scientific, Inc./tx","form":"8-K","filing_date":"2026-05-26","report_date":null,"primary_document":"core-20260526.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1839341/000183934126000005/core-20260526.htm"},"events":[{"id":9189,"run_id":8063,"accession_number":"0001839341-26-000005","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Core Scientific appointed Steve M. Smith to its Board of Directors and Nominating and Corporate Governance Committee, effective May 26, 2026. Smith brings significant experience as former CEO of Equinix and Zayo and as a board member of NextDC, and was determined to be independent.","company_name":"Core Scientific, Inc./tx","ticker":"CORZZ","filing_date":"2026-05-26","form":"8-K","submitted_at":null,"items":[{"id":1705,"accession_number":"0001839341-26-000005","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Steve M. Smith as a member of the Board and the Nominating and Corporate Governance Committee, effective immediately on May 26, 2026. The principal action is a person taking a director role, with detailed disclosure of his qualifications (former CEO of Equinix and Zayo, board member of NextDC) and independence determination. This is a material board appointment that would affect investor assessment of governance and leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:38:02.017753+00:00","company_name":"","ticker":null,"filing_date":""},{"id":1706,"accession_number":"0001839341-26-000005","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure announces the appointment of Steve M. Smith to the Company's Board of Directors and Nominating and Corporate Governance Committee. Although filed under Item 7.01 (Regulation FD Disclosure), the substance is a director appointment, which is a material executive event that would affect investor assessment of the registrant's governance and leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:38:02.017753+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1705,"accession_number":"0001839341-26-000005","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Steve M. Smith as a member of the Board and the Nominating and Corporate Governance Committee, effective immediately on May 26, 2026. The principal action is a person taking a director role, with detailed disclosure of his qualifications (former CEO of Equinix and Zayo, board member of NextDC) and independence determination. This is a material board appointment that would affect investor assessment of governance and leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:38:02.017753+00:00","company_name":"Core Scientific, Inc./tx","ticker":"CORZZ","filing_date":"2026-05-26"},{"id":1706,"accession_number":"0001839341-26-000005","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure announces the appointment of Steve M. Smith to the Company's Board of Directors and Nominating and Corporate Governance Committee. Although filed under Item 7.01 (Regulation FD Disclosure), the substance is a director appointment, which is a material executive event that would affect investor assessment of the registrant's governance and leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:38:02.017753+00:00","company_name":"Core Scientific, Inc./tx","ticker":"CORZZ","filing_date":"2026-05-26"}]}